Emmes Ranked as a Top Biosciences Employer in Greater Washington

ROCKVILLE, Md., May 18, 2020 /PRNewswire/ — Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area.  The ranking is compiled annually by the Washington Business Journal.

Emmes reported revenues of $125 million in 2019 and has more than 750 employees globally.  More than 675 employees work in Maryland, Virginia and Washington, D.C.   

The company is expecting to hire nearly 70 new employees to support new and expanded clinical research projects.  This represents an increase of approximately 10 percent of its area-wide workforce.  The positions include clinical operations staff, biostatisticians, bioinformatics experts, project control analysts, project managers, data management staff, technical writers, clinical research auditors, and proposal manager.  The company has offices in Rockville, MD, Frederick, MD and Tysons Corner, VA.  Emmes continues to maintain a robust teleworking environment.

“We provide the backbone of support to both government and biopharmaceutical companies involved in developing treatments and vaccines associated with a wide range of diseases and disorders,” said Dr. Anne Lindblad, president and chief executive officer.  “Our operational, data management, regulatory, safety,  statistical and data analysis support for clinical trials and human health research is highly valued, and the result is continued growth.  This means promoting employees, giving people more opportunities for job expansion and flexibility, and adding new staff.”

Dr. Lindblad noted that three new executives have joined the leadership team since November: a chief business officer, vice president of clinical operations, and chief medical officer.  Two new business development directors were just hired.  The company also promoted three employees to the position of vice president. 

About Emmes
Emmes is a leading Contract Research Organization working with both public and private sector organizations.  We collaborate with our clients to produce valued, trusted scientific research, and our team members are passionate about making a difference in the quality of human health.  Emmes has supported more than a thousand studies across a diverse range of diseases since our formation in 1977.  Our research is contributing to a healthier world. For more information, visit the Emmes website at www.emmes.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/emmes-ranked-as-a-top-biosciences-employer-in-greater-washington-301060329.html

SOURCE Emmes

Staff

Recent Posts

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB:…

2 hours ago

Mobile-health Network Solutions Announces Closing of Initial Public Offering

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or “the Company”), a…

2 days ago

Biomerica Reports Third Quarter 2024 Financial Results

Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst…

2 days ago

American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione

SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS)…

2 days ago

Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results

Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS…

2 days ago

Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome

Conference call now scheduled for Monday, April 15 at 8:00 a.m. ET Updated registration link…

2 days ago